Document Detail

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.
MedLine Citation:
PMID:  23544184     Owner:  NLM     Status:  MEDLINE    
Cardiac involvement portends a poor prognosis inpatients with sarcoidosis. However, due to the non specific clinical manifestations of the disease, patchy myocardial involvement, and the limited diagnostic yield of diagnostic tests, early diagnosis of cardiac sarcoidosis has been exceedingly difficult. As a result, there is no standardized approach for the early diagnosis of cardiac sarcoidosis. Imaging modalities that can both identify disease and predict response to therapy are paramount to improve management of cardiac sarcoidosis. 18F-FDG PET has many practical advantages in assessing disease activity and monitoring treatment response in patients with cardiac sarcoidosis. Accumulating data support the growing role of 18F-fluorodeoxyglucose (18F-FDG)PET in the diagnosis and risk stratification of patients with cardiac sarcoidosis.
Hicham Skali; Allison R Schulman; Sharmila Dorbala
Related Documents :
10084384 - Detection of abnormal high-frequency components in the qrs complex by the wavelet trans...
10533004 - Flow requirements in ventricular fibrillation: an in vivo nuclear magnetic resonance an...
1706844 - The impact of antitachycardia pacing with defibrillation.
15851194 - Catheter ablation guided by termination of postinfarction ventricular tachycardia by pa...
20338324 - Analysis of the mitral coaptation zone in normal and functional regurgitant valves.
7431984 - Is tricuspid valve repair necessary?
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current cardiology reports     Volume:  15     ISSN:  1534-3170     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-29     Completed Date:  2013-07-23     Revised Date:  2014-05-07    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  352     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiomyopathies / physiopathology,  radionuclide imaging*
Fluorodeoxyglucose F18 / diagnostic use
Multimodal Imaging / methods
Positron-Emission Tomography
Practice Guidelines as Topic
Radiopharmaceuticals / diagnostic use
Sarcoidosis / physiopathology,  radionuclide imaging*
Tomography, X-Ray Computed
Grant Support
Reg. No./Substance:
0/Radiopharmaceuticals; 0Z5B2CJX4D/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Diabetes and Cardiovascular Disease: Original Insights from the Framingham Heart Study.
Next Document:  ED-based protocols speed care to sickle cell patients, reduce repeat ED visits, and discharge admitt...